Related Experiment Video
Updated: Mar 18, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Erratum: Circulating Apo 2L levels decreased in genotype II hepatitis C with pegylated interferon-2 alpha treatment
1Department of Allergy and Clinical Immunology, Antalya Training Hospital, Antalya, Turkey.
Abstract:
Erratum Following publication of the original article (Le Infezioni in Medicina, 2014, vol:22 (4):pp:283-287) we became aware of the following errors in Table 1 and Figure 1 which we wish to correct. These corrections have no impact over the study results, their interpretation or conclusions.
More Related Videos
10:25"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatitis
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes